A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 2, 2007, Pages 193-195

  Douglass, C ^a   Suvarna, K ^b   Reilly, M M ^c   Hawkins, P N ^d   Hadjivassiliou, M ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; PREALBUMIN; PROTEIN GLY53ALA; UNCLASSIFIED DRUG;

ADULT; AMYLOIDOSIS; ANAMNESIS; ARTICLE; ATAXIA; CASE REPORT; DEMENTIA; DEPRESSION; FEMALE; GENE SEQUENCE; HEADACHE; HEART MUSCLE; HEMIPARESIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MUSCLE BIOPSY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSOPAGNOSIA; SCINTIGRAPHY; SLURRED SPEECH; SYMPTOMATOLOGY;

ADULT; ATAXIA; DEMENTIA; DEPRESSION; FEMALE; HEADACHE; HUMANS; MUTATION; PERIODICITY; PERIPHERAL NERVOUS SYSTEM DISEASES; PREALBUMIN; VARIATION (GENETICS);

EID: 33846859081     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.093500     Document Type: Article

References (13)

1. Hund E, Linke RP, Willig F, et al. Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology 2001;56:431-5.
2. Petersen RB, Goren H, Cohen M, et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 1997;41:307-13.
3. Brett M, Persey MR, Reilly MM, et al. Morgan-Hughes. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999;122:183-90.
4. Blevins G, Macaulay R, Harder S, et al. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003;60:1625-30.
5. Herrick MK, DeBruyne K, Horoupian DS, et al. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 1996;47:988-92.
6. Mitsuhashi S, Yazaki M, Tokuda T, et al. MRI analysis on a patient with the V30M mutation is characteristic of leptomeningeal amyloid. Amyloid 2004;11:265-7.
7. Munar-Ques M, Salva-Ladaria L, Mulet-Perera P, et al. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000;7:266-9.
8. Schreiber G, Aldred AR, Jaworowski A, et al. Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus. Am J Physiol 1990;258(Pt 2):R338-45.
9. Dickson PW, Schreiber G. High levels of messenger RNA for transthyretin (prealbumin) in human choroid plexus. Neurosci Lett 1986;66:311-15.
10. Stangou AJ, Hawkins PN. Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol 2004;17:615-20.
11. Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123:1495-504.
12. Ando Y, Terazaki H, Nakamura M, et al. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004;77:345-9.
13. Ellie E, Camou F, Vital A, et al. Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 2001;57:135-7.